Neutrophil gene expression in chronic myeloproliferative disorders.

被引：0
|
作者：
Eagleton, HJ [1 ]
Pellagatti, A [1 ]
Campbell, L [1 ]
Littlewood, TJ [1 ]
Wainscoat, JS [1 ]
Boultwood, J [1 ]
机构：
[1] John Radcliffe Hosp, LRF Mol Haematol Unit, Oxford OX3 9DU, England
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4488
引用
收藏
页码：192B / 192B
页数：1
相关论文
共 50 条
  • [21] The kinetics of clonal dominance myeloproliferative disorders.
    Abkowitz, JL
    Catlin, SM
    Guttorp, P
    BLOOD, 2002, 100 (11) : 586A - 587A
  • [22] Cardiac manifestations in patients with myeloproliferative disorders.
    Galanopoulos, A
    Panou, F
    Matsakas, E
    Grigoraki, V
    Marinakis, T
    Michalis, E
    Anagnostopoulos, NI
    BLOOD, 1999, 94 (10) : 111A - 111A
  • [23] Significantly increased angiogenesis in myeloproliferative disorders.
    Willer, A
    Larosee, P
    Hastka, J
    Saussele, S
    Kuhn, C
    Reiter, A
    Hochhaus, A
    Hehlmann, R
    BLOOD, 2001, 98 (11) : 628A - 629A
  • [24] Usefulness of immunophenotype of myeloproliferative and lymphoproliferative disorders.
    Otaso, JC
    Barcala, VL
    Fantl, D
    Nucifora, E
    Preceruti, A
    Iastrebner, M
    Papalardo, C
    Vinuales, E
    Sasot, A
    Da Graca, I
    Ascione, A
    BLOOD, 1998, 92 (10) : 204B - 204B
  • [25] Comparison of platelet-rich plasma serotonin level and quantitative neutrophil PRV-1 assay in chronic myeloproliferative disorders.
    Koch, CA
    Lasho, TL
    Tefferi, A
    BLOOD, 2004, 104 (11) : 268B - 268B
  • [26] BCR/ABL EXPRESSION IN CHRONIC MYELOPROLIFERATIVE DISORDERS
    Kesaeva, L.
    Misyurin, A.
    Misyurina, E.
    Krutov, A.
    Soldatova, I.
    Kaysina, K.
    HAEMATOLOGICA, 2013, 98 : 346 - 346
  • [27] Prodefensin in plasma of patients with chronic myeloproliferative disorders. A parameter of myelopoietic activity.
    Kamp, S
    Jensen, MK
    Borregaard, N
    BLOOD, 2005, 106 (11) : 629A - 629A
  • [28] Chromosomal anomalies in two coexistent myeloproliferative disorders.
    Potti, A
    Mehdi, S
    BLOOD, 2002, 100 (11) : 346B - 346B
  • [29] Molecular progenitor profiling in human myeloproliferative disorders.
    Jamieson, CHM
    Gotlib, J
    Chao, M
    Mariappan, MR
    LayRaj, M
    Jones, C
    Zehnder, J
    Durocher, J
    Lilleberg, S
    Coutre, S
    Weissman, IL
    BLOOD, 2005, 106 (11) : 38A - 39A
  • [30] Toxicity of treatment with anagrelide for thrombocytosis in myeloproliferative disorders.
    Rosenbaum, H
    Bennet, M
    Braester, A
    Benyamini, N
    Chubar, I
    Rowe, JM
    BLOOD, 2002, 100 (11) : 798A - 798A
12345